Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Antidepressant use higher among younger women opting for oophorectomy due to family history

15 Dec 2019

Women who undergo oophorectomy by the age of 45 years due to family history are more likely to use antidepressants after the procedure, a new study has found.

The study included 2,002 women who underwent oophorectomy due to a family history of cancer. The National Prescription Registry was accessed to determine patterns of antidepressant use. Analyses were stratified according to whether participants were on hormone replacement therapy (HRT) or not. A parallel and age-matched reference group was also included (n=18,018).

Women who underwent oophorectomy by age 45 years were significantly more likely to fill a prescription for an antidepressant in the year following the procedure relative to their comparators (odds ratio [OR], 1.34, 95 percent confidence interval [CI], 1.08–1.65). In contrast, those who underwent surgery at ages 46–55 and >55 years showed no such pattern of antidepressant use.

HRT use was reported in 564 women who received the procedure by age 45 years; the remaining 302 were defined as nonusers.

Notably, when stratifying the analysis according to HRT use status, the heightened use of antidepressants in the year after oophorectomy was only statistically significant in women who were on HRT (OR, 1.51, 95 percent CI, 1.18–1.94). The effect of the procedure was null on those who were not receiving HRT (OR, 1.03, 95 percent CI, 0.70–1.51).

“Whether there is a causal relation between HRT and use of antidepressants or whether this reflects a propensity for concomitant use of HRT and antidepressants in oophorectomized women remains to be discovered,” said researchers. “The increased use of antidepressants following bilateral oophorectomy among previous users of antidepressants implies an increased focus on mental health in this subgroup of oophorectomized women.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.